Abstract
This study investigates the relationship between dietary zinc intake and Helicobacter pylori (H. pylori) seropositivity using a large, representative sample of the US population. The findings suggest that higher dietary zinc intake is significantly associated with a lower prevalence of H. pylori infection. Notably, this association follows an L-shaped pattern, with a threshold point estimated at 24.925 mg/day.
Introduction
Helicobacter pylori is a persistent bacterial pathogen that colonizes the human gastric mucosa, leading to chronic inflammation and serving as a primary risk factor for gastric cancer and peptic ulcers. While standard "triple therapy" (antibiotics combined with a proton pump inhibitor) remains the clinical norm, rising antibiotic resistance has significantly reduced eradication rates, sometimes falling as low as 50% in certain regions.
Consequently, there is growing interest in micronutrients as complementary strategies for the prevention and management of H. pylori. Zinc, an essential trace element, is vital for DNA repair, immune function, and maintaining gastric mucosal integrity. While experimental studies have suggested zinc's inhibitory effects on H. pylori, epidemiological evidence in humans has remained sparse. This study utilizes data from the National Health and Nutrition Examination Survey (NHANES) to clarify this association.
Methods
The researchers conducted a cross-sectional observational study using data from the NHANES 1999–2000 cycle. The study population initially consisted of 9,965 individuals, which was refined to a final cohort of 2,884 adults (aged 20 and older) who provided complete dietary, medical, and laboratory data.
Total zinc intake was calculated by averaging two 24-hour dietary recall interviews, encompassing both food sources and supplements. H. pylori status was determined via serum analysis using an IgG protein enzyme-linked immunosorbent assay (ELISA). Statistical analysis included multivariable logistic regression to calculate Odds Ratios (ORs), adjusting for confounders such as age, BMI, socioeconomic status, and laboratory markers like CRP and albumin. A Generalized Additive Model (GAM) with smooth curve fitting was employed to detect potential non-linear relationships.
Key Results
The study revealed a significant inverse relationship between zinc intake and H. pylori risk. In the fully adjusted model, participants in the highest quartile of zinc intake (Q4) demonstrated a 28% lower risk of seropositivity compared to those in the lowest quartile (Q1) (OR: 0.72; 95% CI: 0.57–0.91).
The most striking finding was the non-linear, "L-shaped" dose-response curve. Using a two-piecewise logistic model, the researchers pinpointed the exact inflection point of the L-curve at 24.925 mg/day. For individuals consuming less than this threshold, each 1 mg/day increase in zinc was associated with a 1.8% reduction in infection risk. However, once intake exceeded this threshold, the association became statistically insignificant (OR: 1.026; p = 0.3868), suggesting a saturation effect where additional zinc provides no further protective benefit.
Discussion and Biological Mechanisms
The observed "saturation effect" suggests that the biological mechanisms through which zinc resists H. pylori—such as mucosal repair or immune modulation—reach a peak capacity. Zinc is known to compete for availability within the gut microbiota and plays a crucial role in activating Toll-like receptors, which serve as the first line of defense against bacterial invasion. Furthermore, zinc's role in maintaining the gastric barrier may prevent the initial colonization and subsequent persistence of the pathogen.
Limitations and Conclusion
While these findings are compelling, the study's cross-sectional design precludes the establishment of causality. The use of 24-hour dietary recalls is subject to recall bias, and the IgG-based ELISA cannot distinguish between active and past infections. Additionally, the results are specific to the US population and may vary in regions with different nutritional contexts or higher rates of zinc deficiency.
In conclusion, higher dietary zinc intake is associated with a reduced prevalence of H. pylori seropositivity in US adults, following an L-shaped threshold pattern. Future prospective studies and randomized controlled trials are necessary to determine if zinc supplementation can effectively prevent or assist in the eradication of H. pylori infections.
Summary updated